Biotech Scan

Scan

Biotech Scan

raw scan snapshot — prices as of scan date, not live 45 rows · screens, not recommendations superseded by2026-04-26-biotech-scanported fromresearch/classic/scans/_archive/2026-03-24-biotech-scan.mdscan slugbiotech-scansource typescan-archive

Biotech in broad distribution — ABBV RSI 28, BMRN RSI 29, MDT RSI 30, A RSI 28 join the oversold ranks. MRNA (+58% 3M) and EXAS (RSI 76) are lone strong-up outliers. NVO death cross deepens (-55% from high). Gene editing names in structural decline.


Quick Snapshot

Signal Reading
Overall 🔴 BEARISH — Broad sector weakness, most large-cap pharma and biotech oversold or approaching
Leaders MRNA ($51.60, RSI 52, +57.6% 3M, strong-up), EXAS ($104.96, RSI 76↑, +41% vs SMA200), PTGX ($98.85, RSI 62, +36% vs SMA200)
Laggards A ($110.47, RSI 28↓), ABBV ($204.91, RSI 28↓), BMRN ($54.25, RSI 29↓), SRPT ($16.74, -83% from high)

Price Table

Stock Price RSI vs SMA20 7D% 30D% 3M% Trend Signal
EXAS $104.96 76 +1.3% +0.3% +1.5% +3.1% strong-up ✨ ⚠️ Overbought
PTGX $98.85 62 +5.4% +5.2% +19.4% +13.1% strong-up ✨ 🔒 Hold
MRNA $51.60 52 -2.9% -6.7% +2.1% +57.6% strong-up ✨ 🔒 Hold
NTLA $13.01 49 -3.6% +0.3% +2.9% +34.1% strong-up ✨ 🔍 Watch
EDIT $2.37 55 +4.3% -8.9% +32.4% +1.7% weak-up 🔍 Watch
ILMN $124.02 49 -0.3% +5.7% +5.4% -9.9% weak-down 🟡 Watch
BIIB $183.81 47 -1.2% -0.8% -5.8% +4.2% weak-down 🟡 Watch
VRTX $455.65 44 -3.9% -3.4% -4.5% -1.0% weak-down 🟡 Watch
TMO $492.20 46 -0.2% +0.4% -4.4% -14.9% down 🟡 Watch
REGN $738.08 42 -3.1% -3.8% -4.4% -5.7% weak-down 🟡 Watch
XBI $120.60 41 -3.6% -1.4% -3.4% -4.2% weak-down 🟡 Watch
LEGN $17.56 41 -6.6% -5.6% -3.1% -22.6% strong-down 💀 🟡 Watch
AMGN $349.97 38 -5.0% -4.3% -8.6% +5.6% weak-down 🟡 Watch
LABU $142.26 39 -12.4% -4.7% -12.8% -19.2% weak-down 🟡 Watch
GILD $137.06 37 -4.8% -5.1% -6.6% +9.7% weak-down 🟡 Watch
CRSP $46.66 38 -12.1% -4.4% -17.8% -17.7% strong-down 💀 🟡 Watch
ALNY $314.53 40 -2.4% -1.8% -6.4% -22.9% strong-down 💀 🟡 Watch
IQV $165.02 38 -2.9% +0.6% -0.4% -26.5% down 🟡 Watch
BNTX $87.69 36 -11.2% -1.7% -20.4% -4.9% down 🟡 Watch
DHR $188.74 33 -5.2% +2.0% -9.9% -17.1% down 🟡 Approaching Oversold
RARE $20.03 34 -8.8% -8.0% -11.8% -42.4% strong-down 💀 🟡 Watch
INCY $90.61 33 -6.0% +0.3% -10.6% -10.0% weak-down 🟡 Approaching Oversold
NVO $36.52 31 -4.3% -3.6% -23.0% -24.1% strong-down 💀 🟡 Approaching Oversold
LLY $901.47 30 -7.8% -5.1% -13.5% -16.2% weak-down 🟢 Oversold
IONS $70.83 31 -7.4% -1.9% -14.8% -12.9% weak-down 🟡 Approaching Oversold
MDT $86.85 30 -4.6% -2.0% -10.2% -10.1% down 🟢 Oversold
BMRN $54.25 29 -8.7% -7.3% -15.3% -8.5% down 🟢 Oversold
ABBV $204.91 28 -7.9% -8.0% -10.3% -10.2% down 🟢 Oversold
A $110.47 28 -5.4% +0.1% -10.1% -20.1% strong-down 💀 🟢 Oversold
DXCM $66.73 42 -4.2% -3.5% -8.7% -0.9% strong-down 💀 🟡 Watch
SRPT $16.74 43 -2.0% -3.2% -11.3% -21.2% strong-down 💀 🟡 Watch

Entry Zones

Stock Entry Zone RSI Thesis
ABBV $195-210 28 Dividend aristocrat, deep oversold
LLY $880-910 30 GLP-1 leader at oversold — rare entry
BMRN $52-56 29 Rare disease leader, approaching capitulation
MDT $84-88 30 Medtech at deep discount

Action Matrix

Stock Signal Action Notes
MRNA ✨ Strong-Up 🔒 Hold Monster rally from lows, +58% 3M
EXAS 🟠 Overbought ⚠️ Don't Chase RSI 76, extended
PTGX ✨ Strong-Up 🔒 Hold +19% 30D, biotech leader
ABBV 🟢 Oversold 📈 Accumulate RSI 28, quality pharma
LLY 🟢 Oversold 📈 Accumulate RSI 30, GLP-1 king
NVO 💀 Death Cross 🔍 Watch -55% from high, Ozempic competition fears
SRPT 💀 Structural ❌ Don't Buy -83% from high
10 events

No direct external sources are attached to this read.